Live feed16:05:00·45dPRReleasevia QuantisnowMyriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian CancerByQuantisnow·Wall Street's wire, on your screen.MYGN· Myriad Genetics Inc.Health Care
